Aims

To support the free and open dissemination of research findings and information on alcoholism and alcohol-related problems. To encourage open access to peer-reviewed articles free for all to view.

For full versions of posted research articles readers are encouraged to email requests for "electronic reprints" (text file, PDF files, FAX copies) to the corresponding or lead author, who is highlighted in the posting.

___________________________________________

Friday, May 4, 2007

Changes in Cardiovascular Risk Factors Associated with Wine Consumption in Intervention Studies in Humans
Annals of Epidemiology
Volume 17, Issue 5, Supplement 1, May 2007, Pages S32-S36


Evidence that links moderate wine consumption to cardiovascular health corresponds mostly to ecological observations. Intervention studies using moderate wine consumption with ischemic heart disease as the end point will probably not be available soon because they require long-term follow-up and adequately randomized experimental groups. In contrast, short-term studies focused on risk factors are feasible and should provide evidence suitable for a critical assessment of the apparent beneficial role of moderate drinking, as well as other lifestyle measures, on cardiovascular health.

Our intervention studies suggest an increase in HDL-cholesterol, decrease in the omega-6/omega-3 ratio, and in some cases a slight increase in triglyceride levels from moderate drinking. Observed changes in hemostasis include reduced coagulation and increased fibrinolysis; effects on blood pressure have been inconsistent. There is a reduction in inflammatory markers and an increase in endothelial function. Effects of wine are greater for subjects on a Mediterranean diet than those on an occidental diet. Several key biochemical or physiological processes related to atherogenesis are positively modified by wine consumption. From our observations, we conclude that wine in moderation and as part of the diet is directly responsible for changes that may help decrease the risk of cardiovascular disease.

Read Full Text (PDF)

Contributor: Philippe Arvers

_________________________________________________________________